Medicine
Cyanocobalamin 30000 mcg/30 mL injection
Cyanocobalamin 30000 mcg/30 mL injection is a generic prescription medicine for intramuscular use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). PROTECT FROM LIGHT Use only if solution is…
Key facts
- Active ingredient (INN)
- Cyanocobalamin
- Brand
- Sold under the generic name
- Strength
- 30000 mcg/30 mL
- Dosage form
- Injection
- Route
- Intramuscular
- Packs
- 5 vials of 30 mL, 10 vials of 30 mL, 1 vial of 30 mL
- Manufacturer
- Vitruvias Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). PROTECT FROM LIGHT Use only if solution is clear and seal intact.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B03BA01 Cyanocobalamin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 February 2020
- Identifiers
- RxCUI 309594DailyMed set ID 2117af8a-723f-4e2f-98a6-83ad2c423751NDC 69680-121Application ANDA209255
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 vial, multi-dose in 1 box / 30 mL in 1 vial, multi-dose | 69680-121-05 | Vitruvias Therapeutics | 12 February 2020 |
| 10 vial, multi-dose in 1 box / 30 mL in 1 vial, multi-dose | 69680-121-10 | Vitruvias Therapeutics | 15 September 2021 |
| 1 vial, multi-dose in 1 box / 30 mL in 1 vial, multi-dose | 69680-121-30 | Vitruvias Therapeutics | 15 September 2021 |
| 1 vial, multi-dose in 1 carton / 30 mL in 1 vial, multi-dose | 70710-1665-1 | — | 5 May 2022 |
| 5 vial, multi-dose in 1 carton / 30 mL in 1 vial, multi-dose | 70710-1665-5 | — | 5 May 2022 |
| 1 vial, multi-dose in 1 carton / 30 mL in 1 vial, multi-dose | 70771-1690-1 | — | 5 May 2022 |
| 5 vial, multi-dose in 1 carton / 30 mL in 1 vial, multi-dose | 70771-1690-5 | — | 5 May 2022 |
| 1 vial, multi-dose in 1 carton / 30 mL in 1 vial, multi-dose | 68083-562-01 | — | 14 October 2022 |
| 5 vial in 1 carton / 30 mL in 1 vial | 70756-637-05 | — | 1 May 2026 |
| 10 vial in 1 carton / 30 mL in 1 vial | 70756-637-10 | — | 1 May 2026 |
| 1 vial in 1 carton / 30 mL in 1 vial | 70756-637-88 | — | 1 May 2026 |
| 1 vial, multi-dose in 1 box / 30 mL in 1 vial, multi-dose | 0517-0130-01 | — | 29 May 2003 |
| 30 mL in 1 vial, multi-dose | 0143-9619-01 | — | 20 October 1971 |
| 10 vial, multi-dose in 1 box / 30 mL in 1 vial, multi-dose | 0143-9619-10 | — | 20 October 1971 |
| 1 vial, multi-dose in 1 carton / 30 mL in 1 vial, multi-dose | 71288-302-30 | — | 15 November 2024 |
| 1 vial, multi-dose in 1 carton / 30 mL in 1 vial, multi-dose | 87188-113-01 | — | 14 October 2022 |
| 5 vial in 1 carton / 30 mL in 1 vial | 70069-171-05 | — | 18 December 2018 |
| 10 vial in 1 carton / 30 mL in 1 vial | 70069-171-10 | — | 18 December 2018 |
| 30 mL in 1 vial, multi-dose | 51662-1394-1 | — | 18 October 2019 |
| 10 pouch in 1 case / 1 vial in 1 pouch / 30 mL in 1 vial | 51662-1703-3 | — | 18 December 2018 |
| 1 vial, multi-dose in 1 bag / 30 mL in 1 vial, multi-dose | 0404-9783-30 | — | 8 May 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 15 September 1949 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Cyanocobalamin 30000 mcg/30 mL injection.
Other strengths and forms of Cyanocobalamin
Clinical summary
Cyanocobalamin is a vitamin B12 indicated for vitamin B 12 maintenance therapy in adult patients with pernicious anemia, among other approved uses. It is available as injection and nasal spray for intramuscular and subcutaneous use. MedsAcross supplies Cyanocobalamin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CyanocobalaminFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Nascobal prescribing information (Par Health) · U.S. National Library of Medicine, DailyMed
Need Cyanocobalamin 30000 mcg/30 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.